CPT® Code 0631T

Transcutaneous visible light hyperspectral imaging measurement of oxyhemoglobin, deoxyhemoglobin, and tissue oxygenation, with interpretation and report, per extremity

Transcutaneous visible light hyperspectral imaging measurement is a non-invasive diagnostic procedure that assesses the levels of oxyhemoglobin and deoxyhemoglobin in the tissue, as well as overall tissue oxygenation. This procedure is particularly significant for individuals suffering from diabetes and peripheral artery disease, conditions that can lead to inadequate blood supply and increase the risk of ischemia, nonhealing wounds, and potential amputations. The technology utilizes hyperspectral imaging to differentiate between the light absorption characteristics of oxygenated and deoxygenated hemoglobin, allowing for precise quantitative measurements without the need for patient contact or the use of contrast agents. The device employed in this procedure is portable, battery-operated, and designed for ease of use, featuring hand grips and a display screen that presents color-coded, two-dimensional images of the oxygenation status of the scanned limb. This imaging technique provides valuable data regarding the oxygenation levels in specific tissue regions, facilitating timely and informed clinical decisions regarding patient care.